Asset Advisors Corp’s Biogen BIIB Stock Holding History

Asset Advisors Corp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$313K	–	164
2016 Q3	$313K	Hold	1,000	–	–	0.07%	89
2016 Q2	$242K	Hold	1,000	–	–	0.05%	95
2016 Q1	$260K	Hold	1,000	–	–	0.06%	95
2015 Q4	$306K	Hold	1,000	–	–	0.07%	91
2015 Q3	$292K	Hold	1,000	–	–	0.07%	90
2015 Q2	$404K	Hold	1,000	–	–	0.09%	84
2015 Q1	$422K	Hold	1,000	–	–	0.09%	83
2014 Q4	$339K	Hold	1,000	–	–	0.07%	89
2014 Q3	$331K	Sell	1,000 -150	-13%	-$49.5K	0.08%	86
2014 Q2	$363K	Hold	1,150	–	–	0.08%	85
2014 Q1	$352K	Sell	1,150 -57	-5%	-$18.1K	0.08%	86
2013 Q4	$337K	Hold	1,207	–	–	0.08%	86
2013 Q3	$291K	Hold	1,207	–	–	0.08%	89
2013 Q2	$260K	Buy	+1,207	New	+$258K	0.08%	91

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Asset Advisors Corp's BIIB Position: Q4 2016 in Review

Asset Advisors Corp sold out of Biogen (BIIB) in Q4 2016, closing a stake of 1,000 shares — an estimated $313K sold.

Asset Advisors Corp first reported a position in BIIB in Q2 2013 and held it in 14 quarters. The position peaked at $422K in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Asset Advisors Corp reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Asset Advisors Corp sold 1,000 Biogen shares in Q4 2016, an estimated $313K.
Asset Advisors Corp first reported a position in Biogen in Q2 2013 and held it in 14 quarters.
Asset Advisors Corp's Biogen position peaked at $422K in Q1 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Asset Advisors Corp's 13F filing for Q4 2016, filed 27 Jan 2017.